Recent News

• 09.03.2025 - 2025 Wells Fargo Healthcare Conference
• 08.27.2025 - Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
• 08.21.2025 - Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
• 08.07.2025 - Dynavax Technologies Second Quarter 2025 Financial Results
• 08.07.2025 - Dynavax Reports Second Quarter 2025 Financial Results
• 07.29.2025 - Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
• 06.16.2025 - Lauren Silvernail

Recent Filings

• 08.25.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.21.2025 - 8-K Current report
• 08.21.2025 - EX-99.1 EX-99.1
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - 8-K Current report
• 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.17.2025 - 8-K Current report